key: cord-0946087-sut294a6 authors: Zhang, Xiaole; Wang, Jing title: Dose-response Relation Deduced for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission date: 2020-10-29 journal: Clin Infect Dis DOI: 10.1093/cid/ciaa1675 sha: 9b086127b0b5fcbbab71989d55cf78f74788f2e2 doc_id: 946087 cord_uid: sut294a6 BACKGROUND: A comprehensive understanding of the transmission routes of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of great importance for the effective control of the spread of Corona Virus Disease 2019 (COVID-19). However, the fundamental dose-response relation is still missing for better evaluating and controlling the infection risk. METHODS: We developed a simple framework to integrate the a priori dose-response relation for SARS-CoV based on mice experiments, the recent data on infection risk from a meta-analysis and the respiratory virus shedding in exhaled breath, to shed light on the dose-response relation for human. The aerosol transmission infection risk was evaluated based on the dose-response model for typical indoor environment. RESULTS: The developed dose-response relation is an exponential function with a constant k in the range of about 6.4×10 (4) to 9.8×10 (5) virus copies, which means that the infection risk caused by one virus copy in viral shedding is on the order of 10 (-6) to 10 (-5). The median infection risk via aerosol transmission with one-hour exposure (10 (-6) to 10 (-4)) was significantly lower than the risk caused by close contact (10 (-1)) in a room of the area from 10 to 400 m (2) with one infected individual in it and with typical ventilation rate 1 ACH (Air Changes per Hour). CONCLUSIONS: The infection risk caused by aerosol transmission was significantly lower than the risk caused by close contact. It is still necessary to be precautious for the potential aerosol transmission risk in small rooms with prolonged exposure duration. Control of the spread of Corona Virus Disease 2019 is the urgent challenge throughout the world. A comprehensive understanding of the transmission routes of the causal pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is of great importance for effective control. Human-to-human transmission by close contact where large respiratory droplets play a significant role has been established as the main transmission route 1 . At the same time the transmission by microscopic respiratory particles (aerosol) is getting increasing attention. A recent open letter from 239 scientists 2 appealed to the relevant communities and organizations to recognize the potential transmission of SARS-CoV-2 through aerosol. There is no distinct boundary between droplets and aerosol in nature so it is natural to investigate the infection risk due to aerosol. A quantitative assessment of the infection risk through different transmission routes is essential to evaluate their relative importance and to prioritize the control measures. However the fundamental dose-response relation is still missing for any quantitative assessment. In this study, we developed a simple framework to integrate the a priori dose-response relation for SARS-CoV 3 based on mice experiments, the recent data on infection risk 4 from a systematic review and meta-analysis and respiratory virus shedding in exhaled breath 5 , to shed light on the doseresponse relation for human, and applied the developed dose-response relation to quantitatively evaluate the infection risk via aerosol transmission in a simple illustrative indoor scenario using Quantitative Microbial Risk Assessment (QMRA). Figure 1 shows the schematic diagram of this study. The utilized data and methods would be introduced in this section. Watanabe et al. 3 found that the exponential model p=1−exp(−d/k) could well depict the doseresponse relation based on the experiments challenging mice with recombinant SARS-CoV variants 6 and Murine Coronavirus Strain 1 (MHV-1) 7 , where p is the infection probability, d is the exposure dose, and k is the pathogen dependent parameter. Based on Taylor's Formula, we could derive that p ~ d/k, applicable when the infection risk is relatively low, e.g. below 15%, with the relative difference between p and d/k smaller than 8 percent. We assume that the exponential model remains applicable for the dose-response relation for human. A recent study reported by the WHO COVID-19 Systematic Urgent Review Group Effort (SURGE) 4 indicated that the anticipated probability of viral infection is about 12.8% within 1 m and about 2.6% at further distance through a systematic review and meta-analysis on the betacoronaviruses causing severe acute respiratory syndrome (SARS), Middle East Respiratory Syndrome (MERS) and COVID-19. This important information provided us a unique opportunity to assess the dose-response relation of the viruses, if the exposure dose could be appropriately estimated. Recently, Leung et al. 5 investigated the respiratory shedding of coronaviruses (NL63, OC43, HKU1 and 229E) in exhaled breath in real-life situations with breathing and coughing. The results showed that about 30% to 40% of the symptomatic individuals in the tests produced viral shedding (E virus ) in respiratory particles, with about 10 2 to 10 5 virus copies in samples of 30 min without wearing masks, with a geometric mean of about 10 4 . The recent studies 8, 9 have shown that the respiratory viral loads were about 10 6 to 10 8 copies ml -1 . The viral shedding was estimated to be 10 2 to 10 4 copies per hour based on the particle number emission and size distribution for mouth breathing 10 following the method proposed by Zhang et al. 11 . The results were in line with the measurements of the respiratory shedding of coronaviruses in exhaled breath. An overall effective dilution rate is required to convert the viral shedding into the exposure dose at various distances. The overall effective dilution rate should be a combination of various factors, e.g. the dilution when the exhaled air is mixed with the ambient air and the possibility for the exposed person to actually inhale the contaminated plume. The meta-analysis study 4 offered a plausible way to estimate this factor. It was shown that the probability of viral infection decreased by about a factor of 5 from within 1 m (12.8%) to further distance (2.6%). According to the exponential model, the dose-response relation is nearly linear within the range of p < 15% (k is a constant), which suggests that the viral dose should also be effectively diluted by about the same magnitude. Therefore we used 5 as the effective dilution factor (f dilu ) to estimate the exposure doses corresponding to the infection risks from the meta-analysis. It was reported in the meta-analysis 4 that the duration of exposure varied from any duration to a minimum of 1 h. Here we used 1 h as a representative duration (t expo ), which was close to the total duration of close contact between a nurse / health worker and a patient per day 12 . The deposition ratio (f dep ) of the particles onto the mucus of the respiratory system was estimated based on the size distribution 10 of particles generated by breathing and coughing and the deposition model for bioaerosols 13 . The overall deposition ratio was about 90%. The exposure (virus copies) at further distance was estimated as d =E virus /(f dilu )·t expo ·f dep . Monte Carlo simulations were conducted to estimate the exposure dose. It was assumed that 40% of the infected individuals had positive viral shedding (E virus ), which followed log-normal distribution log 10 (E virus )~Normal(4, 0.5). One million values of E virus were generated for the simulation. The infection risk from the meta-analysis 4 was the total risk through all the routes, e.g. airborne viruses and contact transmission. The contribution from airborne virus-laden particles to the total exposure dose was uncertain. As a result, the dose-response relation was estimated based on 5 different contribution levels (0.1, 0.25, 0.5, 0.75 and 1) of airborne virus-laden particles to the total exposure dose. The Monte Carlo simulations for exposure dose were conducted by MATLAB codes. The parameter k in the dose-response relation was fitted by the nonlinear regression method in the Statistics and Machine Learning Toolbox in MATLAB R2019b, based on the exposure dose levels and the infection risk. Here, we utilized the developed dose-response relation, combined with a box model for the exposure estimation, to quantitatively evaluate the infection risk of SARS-CoV-2 through aerosol transmission and compared with the risk due to close contact based on the QMRA methodology. We considered a simple illustrative scenario of a room with one infected individual with positive viral shedding in it. The room area varied from 10 to 400 m 2 and the height was fixed at 3 m. The ventilation rate varied from 0.1 to 2 ACH (Air Changes per Hour), with 1 ACH being the typical ventilation rate for offices 14 . Monte Carlo simulations were conducted to assess the risk for representative exposure duration of 1 h. A box model 11 was employed to estimate the virus concentration and deposition in the room. The box model assumed that the airborne virus-laden particles were well mixed and the virus concentration was homogeneous in the room. The positions of the infected individual and other occupants of the room, their movements, and detailed ventilation pattern, which could vary strongly from one case to another, were not considered. The approach aims at quantifying the typical risk level in representative scenarios, and is widely adopted in epidemic modeling 15 . The key processes were integrated in the evaluation model, including the viral shedding, dispersion, deposition in air, biologic decay and lung deposition. A recent study based on computational fluid dynamics 16 indicated the aerosol mainly remained below 2 m for indoor environment, so 2 m was utilized as the mixing height instead of the room height (3 m). Four key processes were considered in the model, i.e. viral shedding, biologic decay, ventilation and deposition. In the Monte Carlo simulations, the viral shedding was a stochastic variable following the distribution log 10 (E virus )~Normal(4, 0.5). The half-life period of the virus followed the triangular distribution with the lower limit, upper limit and mode of log 10 (0.5), log 10 (100) and log 10 (10) based on the data reported in the literature 11 . The deposition velocities were estimated following the method proposed by Lai et al. 17 based on the size distribution 10 of particles generated by breathing and coughing. For the exposure estimation, the total respiratory volume was assumed to be 0.6 m 3 per hour and the deposition of particles in the respiratory system was estimated by lung deposition model for bioaerosols 13 . In the dose-response model, it was assumed that k was a stochastic variable following the triangular distribution with lower limit, upper limit and mode of 6.4×10 4 , 9.8×10 5 and 1.6×10 5 copies. The final dose-response estimations for k are from 6.4×10 4 to 9.8×10 5 copies dependent on the contribution of the airborne virus-laden particles to the total dose as shown in A recent study 19 intranasally challenged ferrets with a range of titres of SARS-CoV-2 strain Victoria/1/2020 20 (5×10 2 , 5×10 4 and 5×10 6 PFU). It was shown that 5×10 4 and 5×10 6 PFU caused 100% infection; the dose of 500 PFU caused 1 infection out of 6 ferrets (17%). Our dose-response curve with the k of 9.8×10 5 copies (airborne particles contribution level 0.1) gave rise to similar infection risks of about 100%, 100% and 15% respectively for the doses of 5×10 6 , 5×10 4 and 5×10 2 PFU. The comparison with the ferret results is shown in Figure 2 . The animal models are different from humans and the conversion factor from PFU to virus copies is still uncertain, nonetheless, the reasonable agreement is encouraging. Further studies are needed to evaluate and refine the developed dose-response relation. As shown in Figures S1 to S3 in Supporting Information (SI), two different fractions (40%, 100%) of the infected individuals for positive viral shedding and two distributions log 10 (E virus )~Normal(4, 0.5) and log 10 (E virus )~Uniform (3, 5) were utilized to evaluate the sensitivities of the estimations to the chosen parameters. The variations of the dose-response curves among different settings were limited, demonstrating the stability of the estimations. The results indicated that the median infection risk to contract COVID-19 via the aerosol route was about 2.3×10 -5 (95% confidence interval: 2.0×10 -6 to 3.2×10 -4 ) in a room with the area of 100 m 2 with 1 ACH ( Figure 3) , which was more than three orders of magnitude lower than the risk due to close contact (about 12.8% within 1 m) based on the meta-analysis 4 . The infection risk due to close contact with an infected person is complicated and could be mainly attributed to three different factors as shown in Figure S4 in SI: (1) Respiratory droplets with significant amount of liquid: produced by coughing, sneezing, singing, talking, or breathing. The droplets could be inhaled or deposited on mucous membranes; (2) Aerosol (droplet nuclei after evaporation of the volatile part in small droplets): the exhaled plume is not fully diluted, and the aerosol concentration is high for close contact; (3) Direct/indirect contact with the infected person: physical contact with the infected individual or the surfaces contaminated by the infected individual. It is extremely difficult to distinguish the contribution of each part. The meta-analysis indicated the overall close contact infection risk including all the potential routes. It is suggested that the respiratory droplets might play an important role in the transmission through close contact 1 . Measurements indicated that the viral shedding in respiratory droplets was comparable to that in the aerosols 5 . The exposure dose would be high if the respiratory droplets were inhaled or deposited on mucous membranes. The recent report (updated Oct. 5, 2020) of Centers for Disease Control and Prevention (CDC) 21 also suggested respiratory droplets as a main route for the transmission. The CDC report 21 also suggested that spread from touching surfaces was not thought to be a common way for the transmission. The framework for the dose-response estimation is kept as simple as possible to avoid unnecessary uncertainties. The developed dose-response relation provides a tool to quantify the magnitude of the infection risk. The meta-analysis and evidence based study provide a new opportunity to estimate the human dose-response relation. In the future, the uncertainties could be reduced by using new technology, e.g. personal IoT (internet of things) devices, to record the distance, exposure duration, and environmental factors, which could greatly improve the quality of exposure dose estimation and thus the dose-response relation. The developed dose-response relation could be utilized to quantify the magnitude of the infection risk via aerosol transmission. The uncertainties in the estimations were mainly due to the doseresponse relation and the viral shedding. Despite the uncertainties, the assessment could still improve the understanding of the relative importance of different transmission routes. The median infection risk via aerosol transmission with one hour exposure (10 -6 to 10 -4 ) in the illustrative scenario was significantly lower than the risk caused by close contact (10 -1 ). Keeping distance is not enough to prevent the exposure to aerosol indoors. Wearing masks is helpful. The infection risk via aerosol transmission could increase for prolonged exposure duration, e.g. at home and office. In addition, the expected number of infected cases could be considerable if there are a large amount of exposed individuals, e.g. in clubs. As a result, it is necessary to be precautious for the potential aerosol transmission risk in such situations. The ventilation rates are usually higher in healthcare facilities, which could reduce the infection risk. Increasing the ventilation to about 9 ACHs, which are normally utilized in the healthcare facilities 14 , made the risk about 3 times lower than the situation with 1 ACH 11 . However, the aerosol-generating procedures (AGPs) on patients are likely to generate higher viral shedding. Further information about the viral shedding during AGPs is needed to better quantify the infection risk and protect clinicians. J.W. conceived the study. J.W. and X.Z. designed the development procedures. X.Z. developed the calculation code. X.Z. and J.W analyzed the results and wrote the paper. Transmission of SARS-CoV-2: implications for infection prevention precautions (WHO Scientific Brief It is Time to Address Airborne Transmission of COVID-19 Development of a Dose-Response Model for SARS Coronavirus Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis Respiratory virus shedding in exhaled breath and efficacy of face masks Pathogenicity of severe acute respiratory coronavirus deletion mutants in hACE-2 transgenic mice Murine Hepatitis Virus Strain 1 Produces a Clinically Relevant Model of Severe Acute Respiratory Syndrome in A/J Mice SARS-CoV-2 respiratory viral loads and association with clinical and biological features Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants. medRxiv Size distribution and sites of origin of droplets expelled from the human respiratory tract during expiratory activities A Case Study Evaluating the Risk of Infection from Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) in a Hospital Setting Through Bioaerosols Enhancement of ICRP's Lung Deposition Model for Pathogenic Bioaerosols Ventilation and indoor air quality in retail stores: A critical review (RP-1596) Estimation of airborne viral emission: Quanta emission rate of SARS-CoV-2 for infection risk assessment Modelling aerosol transport and virus exposure with numerical simulations in relation to SARS-CoV-2 transmission by inhalation indoors MODELING INDOOR PARTICLE DEPOSITION FROM TURBULENT FLOW ONTO SMOOTH SURFACES Dose-dependent response to infection with SARS-CoV-2 in the ferret model Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia Centers_for_Disease_Control_and_Prevention_(CDC). How COVID-19 Spreads The authors declare no competing interests. The code for the calculation is available from J.W. (jing.wang@ifu.baug.ethz.ch) upon reasonable request.